Fingerprint
Dive into the research topics where Cancer Institute of New Jersey (CINJ), Cancer Pharmacology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Research output
-
Maf1 is an intrinsic suppressor against spontaneous neural repair and functional recovery after ischemic stroke
Tsang, C. K., Mi, Q., Su, G., Hwa Lee, G., Xie, X., D'Arcangelo, G., Huang, L. & Steven Zheng, X. F., Sep 2023, In: Journal of Advanced Research. 51, p. 73-90 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma
Zhang, H., Su, X., Burley, S. K. & Steven Zheng, X. F., 2022, In: Theranostics. 12, 8, p. 3518-3533 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Nuclear SOD1 in Growth Control, Oxidative Stress Response, Amyotrophic Lateral Sclerosis, and Cancer
Xu, J., Su, X., Burley, S. K. & Zheng, X. F. S., Feb 2022, In: Antioxidants. 11, 2, 427.Research output: Contribution to journal › Review article › peer-review
Open Access